Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (311-320 of 341) with videos related to

Pageof 35
Sort By:
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Autoimmunity Reviews|July 15, 2020
2020 international consensus on ANCA testing beyond systemic vasculitisSergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Pageof 35

Showing results (311-320 of 341) with videos related to

Sort By:
Pageof 35
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Autoimmunity Reviews|July 15, 2020
2020 international consensus on ANCA testing beyond systemic vasculitisSergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis with Polyangiitis: Findings from a Large European CohortMatthias Papo, Pauline Martinot, Renato A Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Pageof 35